Document is current
Any future updates will be listed below
-
Authors
Perez-Lopez, Raquel http://orcid.org/0000-0002-9176-0130
Ghaffari Laleh, Narmin http://orcid.org/0000-0003-0889-3352
Mahmood, Faisal http://orcid.org/0000-0001-7587-1562
Kather, Jakob Nikolas http://orcid.org/0000-0002-3730-5348
- License Information
-
More Information
Article History
Accepted: 9 April 2024
First Online: 16 May 2024
Competing interests
: J.N.K. declares consulting services for Owkin, DoMore Diagnostics, Panakeia, Scailyte, Mindpeak and MultiplexDx; holds shares in StratifAI GmbH; has received a research grant from GSK; and has received honoraria from AstraZeneca, Bayer, Eisai, Janssen, MSD, BMS, Roche, Pfizer and Fresenius. R.P.-L. declares research funding by AstraZeneca and Roche, and participates in the steering committee of a clinical trial sponsored by Roche, not related to this work. All other authors declare no competing interests.
